20 Sep Axonics defeats Medtronic lawsuit in spine-stimulation patent trial

SANTA ANA, CA – Following an eight-day trial in California federal court, medical device maker Axonics has convinced a jury that it did not violate rival Medtronic’s patents related to its bladder and bowel control device. Axonics CEO Raymond Cohen said in a statement that he was pleased with the verdict and that Medtronic’s lawsuit had been meant to “stifle competition, limit patient and physician choice, and protect the incumbent’s monopoly in sacral neuromodulation.”

Impact Trial worked alongside Tensegrity Law Group LLP, on behalf of their client Axonics Modulation Technologies Inc.

Congratulations to our Impact members Bill Weir, Nelly Lin, Ouliana Nikolaeva-Hir, Rou Wen, Julia Lunavictoria, Aaron Pitera, William Pineda, Grace Cho, Christine Chen, Mike Stovall, Mindy Cho, and Justin Chauncey who worked diligently to achieve a win on this matter. We are so proud of you all!

The case is Medtronic Inc. et al. v. Axonics Modulation Technologies Inc., case number 8:19-cv-02115, in the U.S. District Court for the Central District of California.